Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ambion

1989 FOUNDED
M&A STATUS
201-300 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Developer of RNA-based reagents for life science research. The company offers molecular biology products, enzymes, drug development, life science research and other RNA-based products.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 2130 Woodward Street
  • Austin, TX 78744
  • United States

Ambion Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Ambion‘s full profile, request access.

Request full access to PitchBook

Ambion Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Ambion‘s full profile, request access.

Request full access to PitchBook

Ambion Executive Team (1)

Name Title Board
Seat
Contact
Info
Matthew Winkler Ph.D Founder & Chief Executive Officer